Keemun atractylodes macrocephala koidz polysaccharide as well as preparation method and application thereof

By extracting and applying Qimen Atractylodes macrocephala polysaccharide, the problem of treatment of ulcerative colitis is solved, the treatment effect of efficient and low side effects is achieved, and the industrial application of Chinese herbal polysaccharides is simplified.

CN118930670APending Publication Date: 2024-11-12ANHUI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410846612.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-06-27
Publication Date
2024-11-12

AI Technical Summary

Technical Problem

The prior art is difficult to treat ulcerative colitis efficiently and with low side effects, and the industrial application of Chinese herbal polysaccharides is limited by the extraction method and structural complexity, and there is a lack of effective drugs that are easy to prepare.

Method used

Using Qimen Atractylodesis polysaccharide, a polysaccharide with a weight average molecular weight of 3000-4000 Da was obtained through a specific extraction method, with a structure of β-D-Fruf-[(2→1)-β-D-Fruf]n-(2→1) -α-D-Glcp, used to increase the content of short-chain fatty acids in the colon and inhibit inflammatory cells, prepare drugs for the treatment of ulcerative colitis.

Benefits of technology

Qimen Atractylodes macrocephala polysaccharide significantly reduces inflammatory cells, reduces DAI index, improves colon pathological status, has significant therapeutic effects, has few side effects, and is easy to produce in industrialized production.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118930670A_ABST
    Figure CN118930670A_ABST
Patent Text Reader

Abstract

The invention discloses Qimen atractylodes macrocephala koidz polysaccharide as well as a preparation method and application thereof. The weight-average molecular weight of the Qimen atractylodes macrocephala koidz polysaccharide is 3000-4000 Da, the structural formula of the Qimen atractylodes macrocephala koidz polysaccharide is beta-D-Fruf-[(2-> 1)-beta-D-Fruf] n-(2-> 1)-alpha-D-Glcp, and the molar ratio of Glcp to Fruf is 1: (10-20). Wherein Fruf represents a fructose residue, Glcp represents a glucose residue, and 2 to 1 represents a glucosidic bond. The Qimen atractylodes macrocephala koidz polysaccharide is a novel polysaccharide with specific molecular weight and structural composition, has various pharmacological effects of increasing the content of short-chain fatty acid in colon contents, transferring the short-chain fatty acid to colon tissue cells and the like, and is remarkable in curative effect, small in side effect, simple in preparation method and suitable for industrial production when being used for treating ulcerative colitis. The industrial production is easy to realize.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of traditional Chinese medicine polysaccharides, and particularly relates to Qimen Atractylodes macrocephala polysaccharide and a preparation method and application thereof. Background Art

[0002] Ulcerative colitis (UC) is a chronic nonspecific inflammatory disease, which is mainly manifested by pathological intestinal mucosal damage, ulcers, colon contraction, diarrhea and bloody stools. Currently, the commonly used drugs for the treatment of UC are mesalazine, sulfasalazine, etc. However, these drugs also bring certain side effects while treating the disease, such as causing headaches and leading to chronic hepatitis. Therefore, it is urgent to find therapeutic drugs that can fully exert their therapeutic effects and have a lower adverse prognosis.

[0003] Traditional Chinese medicine polysaccharides have gradually entered the field of vision of scientists due to their mild effects. How to extract polysaccharides from traditional Chinese medicines efficiently and with high purity is the primary problem restricting their industrial application. At present, the extraction methods of traditional Chinese medicine polysaccharides include solvent extraction, enzymatic hydrolysis and ultrasonic extraction, etc. These methods have their own advantages in the extraction of different traditional Chinese medicine polysaccharides. The results of studying different polysaccharides and their different extraction methods show that in addition to affecting the polysaccharide extraction rate, the chemical structure analysis and pharmacological activity of polysaccharides will also be affected to a certain extent by different extraction methods. On the other hand, the structure of traditional Chinese medicine polysaccharides is complex and can be divided into primary, secondary, tertiary and quaternary structures. Each level of polysaccharide structure is closely related to its biological activity. The primary structure includes the molecular weight of the polysaccharide, the monosaccharide composition and ratio, the absolute configuration of the residue (D-type or L-type), the ring type (furan ring or pyran ring), the anomeric form of the monosaccharide residue (α- or β-), the connection method, and the hydroxyl substitution position. The secondary, tertiary and quaternary structures are the higher-order structures of polysaccharides, which are spatial structures formed on the basis of the primary structure of polysaccharides through a large number of non-covalent interactions (hydrogen bonds, ionic bonds, van der Waals forces and hydrophobic interactions). It is worth noting that the primary structure determines the higher-order structure to a large extent and is the basis for studying its biological activity. However, different types of Chinese medicine polysaccharides have different effects, and the polysaccharide effects and contents of Chinese medicines of the same type and different origins are also different. At present, there is a lack of Chinese medicine polysaccharides that have good therapeutic effects on ulcerative colitis and are easy to achieve industrial preparation. Summary of the invention

[0004] In view of the deficiencies in the prior art, the present invention provides a Qimen Atractylodes macrocephala polysaccharide and a preparation method and application thereof. The Qimen Atractylodes macrocephala polysaccharide has a novel structure, good efficacy in treating ulcerative colitis, few side effects and is easy to prepare.

[0005] In a first aspect of the present invention, a Qimen Atractylodes macrocephala polysaccharide is provided, the weight average molecular weight of which is 3000-4000 Da, and the structural formula is: β-D-Fruf-[(2→1)-β-D-Fruf] n -(2→1)-α-D-Glcp, in terms of molar ratio, Glcp:Fruf=1:10-20; wherein Fruf represents a fructose residue, Glcp represents a glucose residue, and 2→1 represents a glycosidic bond.

[0006] According to a specific embodiment of the present invention, the weight average molecular weight of Qimen Atractylodes macrocephala polysaccharide is 3267 Da.

[0007] According to a specific embodiment of the present invention, in terms of molar ratio, Glcp:Fruf=1:13.

[0008] The second aspect of the present invention provides the use of the aforementioned Qimen Atractylodes macrocephala polysaccharide in the preparation of a medicament for treating ulcerative colitis.

[0009] According to a specific embodiment of the present invention, the drug is any one of the following 1) to 3): 1) a drug that increases the content of short-chain fatty acids in the colon; 2) a drug that inhibits the activity of histone deacetylase 2; 3) a drug that increases the content of monocarboxylate transporter.

[0010] The third aspect of the present invention provides a method for preparing the aforementioned Qimen Atractylodes macrocephala polysaccharide, comprising: drying and crushing the Qimen Atractylodes macrocephala, then adding a lipophilic solvent to perform a first extraction, filtering the extract to obtain a precipitate, and drying to obtain a defatted Qimen Atractylodes macrocephala; adding water to the defatted Qimen Atractylodes macrocephala for a second extraction, concentrating the extract and then performing alcohol precipitation, centrifuging to obtain the precipitate, and obtaining a crude Qimen Atractylodes macrocephala polysaccharide.

[0011] According to a specific embodiment of the present invention, the lipophilic solvent is ethanol with a concentration of 85-95% v / v, and the conditions of the first extraction include: the extraction solid-liquid ratio is 20g:400-600mL, and reflux extraction is 1-3h.

[0012] According to a specific embodiment of the present invention, the conditions for the second extraction include: the solid-liquid ratio of the extraction is 1 g:20-30 mL, the extraction temperature is 85-95° C., and the extraction time is 2-3 h.

[0013] According to a specific embodiment of the present invention, the conditions for the second extraction include: the solid-liquid ratio of the extraction is 1 g:25 mL, the extraction temperature is 85° C., and the extraction time is 2.5 h.

[0014] According to a specific embodiment of the present invention, the preparation method further comprises: destarch, deproteinize, decolorize and perform column chromatography separation on the crude Qimen Atractylodes macrocephala polysaccharide to obtain a pure Qimen Atractylodes macrocephala polysaccharide.

[0015] The beneficial effects of the present invention are:

[0016] The Qimen Atractylodes macrocephala polysaccharide provided by the present invention is a novel polysaccharide with a specific molecular weight and structural composition. Animal experiments show that it can increase the content of short-chain fatty acids (especially butyrate) in colon contents, upregulate the expression of MCT-1 in colon tissue cells, enhance the transport of short-chain fatty acids to colon tissue cells, and enable butyrate to reduce inflammatory cell CD68 by inhibiting HDAC2. + The amount of inflammatory factors (IL-6, TL-1β and TNF-α) was inhibited, the weight loss of UC mice was effectively alleviated, the DAI index score was reduced, the colon pathological state was improved, and the ulcerative colitis was treated. The Qimen Atractylodes macrocephala polysaccharide of the present invention is used to treat ulcerative colitis with significant efficacy, small side effects, simple preparation method, low raw material cost, and easy to realize industrial production. BRIEF DESCRIPTION OF THE DRAWINGS

[0017] Figure 1 The results of single factor investigation on the extraction conditions of Qimen Atractylodes macrocephala polysaccharide are as follows: (A): solid-liquid ratio, (B): temperature, (C): time, (D): extraction times;

[0018] Figure 2 This is the full-wavelength UV scanning spectrum of Qimen Atractylodes macrocephala polysaccharide in the range of 200-900nm;

[0019] Figure 3 This is the HPGPC diagram of Qimen Atractylodes macrocephala polysaccharide;

[0020] Figure 4 The ion chromatograms of the mixed monosaccharide standard and Qimen Atractylodes macrocephala polysaccharide sample;

[0021] Figure 5 This is the infrared spectrum of Qimen Atractylodes macrocephala polysaccharide;

[0022] Figure 6 Qimen Atractylodes macrocephala polysaccharide 1 H NMR spectrum;

[0023] Figure 7 Qimen Atractylodes macrocephala polysaccharide 13 C NMR spectrum;

[0024] Figure 8 This is the HSQC spectrum of Qimen Atractylodes macrocephala polysaccharide;

[0025] Fig. 9 This is the HMBC spectrum of Qimen Atractylodes macrocephala polysaccharide sample;

[0026] Fig.10 This is the possible structural model of Qimen Atractylodes macrocephala polysaccharide;

[0027] Fig.11 Colon histopathological results of mice in each group (scale bar = 20 μm);

[0028] Fig.12 This is the effect of Qimen Atractylodes macrocephala polysaccharide and Haozhou Atractylodes macrocephala polysaccharide on the levels of proinflammatory cytokines IL-1β, IL-6 and TNF-α in the serum of mice with DSS-induced colitis; compared with the control group, ## p<0.01; compared with the model group, ** p<0.05 (n=3);

[0029] Fig.13 CD68 in the colon of each group of mice + Results of expression levels in immune cells (scale bar = 100 μm);

[0030] Fig.14 The expression of tight junction proteins in the colon of each group of mice (scale bar = 20 μm);

[0031] Fig.15 is the expression of MCT-1 in the colon of each group of mice (scale bar = 20 μm);

[0032] Fig.16 The effect of Qimen Atractylodes macrocephala polysaccharide and Haozhou Atractylodes macrocephala polysaccharide on the expression level of HDAC2 protein in the colon of mice with DSS-induced colitis; compared with the normal control group, ** p<0.01; compared with the model group, ## p<0.01 (n=3);

[0033] Fig.17 The changes in the content of SCFAs in the colon contents, (A): acetic acid, (B): propionic acid, (C): butyric acid, (D): isobutyric acid, (E): valeric acid, (F): isovaleric acid; compared with the control group, ** p<0.01; compared with the model group, ## p<0.05(n=3). DETAILED DESCRIPTION

[0034] In order to make the purpose, technical solution and advantages of the embodiments of the present invention clearer, the technical solution in the embodiments of the present invention is clearly and completely described below. Obviously, the described embodiments are part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0035] Example 1 Preparation of Qimen Atractylodes macrocephala polysaccharide

[0036] Weigh 20g of dried Qimen Atractylodes macrocephala, grind it into coarse particles, soak it in 75% v / v ethanol for 24h, filter it with gauze, and leave the Qimen Atractylodes macrocephala particles. Add 500mL of 90% v / v ethanol, heat and reflux for 2h, twice, filter it with gauze, dry the precipitate naturally and collect it. Add distilled water to the precipitate with a solid-liquid ratio of 1g:25mL, heat it in an 85℃ water bath for 2.5h, after three operations, combine the filtrate, and rotary evaporate it at 60℃ to reduce the volume by 3 / 4. Put the concentrate on a magnetic stirrer, add anhydrous ethanol to make the ethanol concentration reach 80%, seal it, stir it for 1h, and then place it in a refrigerator at 4℃ overnight. After centrifugation at 3000rpm for 10 minutes, store the lower solid in a conical flask, add 100mL of distilled water to dissolve it, and record it as QAMP solution. Prepare 4mg / mL α-amylase solution, add it to the QAMP solution, and heat and stir in a 55℃ water bath for 30min. After removing the starch from the crude polysaccharide, use the Sevage method to remove the protein impurities contained in the crude product. That is, add Sevage reagent (n-butanol: chloroform = 1:4) to the QAMP solution after starch removal at a volume ratio of 3:1, seal, magnetically stir overnight, centrifuge, take the supernatant, and continue to centrifuge the remaining solid until no liquid is produced, and combine the solutions. Repeat the above operation for secondary alcohol precipitation, add Sevage reagent, stir for 5h, and then centrifuge. The treated polysaccharide solution is rotary evaporated until there is no organic reagent and set aside. Add 0.5g activated carbon to the polysaccharide solution, magnetically stir in a 50℃ water bath for 10 minutes, and decompress and filter out the activated carbon to complete the decolorization of the QAMP solution.

[0037] After testing, the extraction rate of Qimen Atractylodes macrocephala polysaccharide was 27.37% after water extraction, and the content of Qimen Atractylodes macrocephala polysaccharide was 90.67% and the content of uronic acid was 0.679% after removing starch, removing protein by Sevage method and decolorizing. Neutral Qimen Atractylodes macrocephala polysaccharide was obtained by DEAE cellulose-52 column chromatography, and then separated by Sephadex G-100 column chromatography to obtain high-purity Qimen Atractylodes macrocephala polysaccharide with uniform molecular weight.

[0038] Example 2 Study on the screening of the preparation process of Qimen Atractylodes macrocephala polysaccharide

[0039] 1. Single factor investigation

[0040] The medicinal materials contain fat-soluble components, which will affect the extraction efficiency. Therefore, ethanol was used to remove the fat-soluble substances contained in the medicinal materials of Qishu, and the polysaccharides were extracted by water extraction and alcohol precipitation. The effects of variables (solid-liquid ratio, temperature, time and number of times) on the polysaccharide extraction rate were investigated.

[0041] (1) Influence of material-liquid ratio

[0042] The water extraction temperature was set at 80°C, ultrapure water was used as the extraction solvent, and reflux extraction was performed for 2 h at a solid-liquid ratio of 1:10, 1:15, 1:20, 1:25 and 1:30, respectively. The polysaccharide extraction rates were measured once.

[0043] (2) Effect of temperature

[0044] The solid-liquid ratio was set at 1:20, and the extraction temperatures were 65°C, 70°C, 75°C, 80°C, 85°C, 90°C and 95°C for 2 h, and the extraction times were once, and the polysaccharide extraction rates were measured respectively.

[0045] (3) Impact of time

[0046] The extraction temperature was set at 80°C, the solid-liquid ratio was 1:20, the extraction times were once, and reflux extraction was performed for 0.5h, 1h, 1.5h, 2h, 2.5h and 3h respectively, and the polysaccharide yield of each group was determined.

[0047] (4) Impact of frequency

[0048] The solid-liquid ratio was set at 1:20, the temperature was 80°C, and the reflux extraction was performed once, twice, three times and four times respectively. Each reaction lasted for 2 hours, and the polysaccharide yield of each group was determined.

[0049] 2. Polysaccharide extraction rate under different extraction conditions

[0050] By analyzing and plotting the changes in polysaccharide extraction rates under different extraction conditions, the results are as follows: Figure 1 As shown. Figure 1 As shown in A, when the solid-liquid ratio reaches 1:30, the polysaccharide yield reaches the maximum value. The yield at a solid-liquid ratio of 1:25 is similar to that at 1:30, but the polysaccharide extraction rates under both conditions are significantly greater than those at a solid-liquid ratio of 1:20. It is speculated that this experimental result is mainly due to the fact that polysaccharides are easily soluble in water. With the increase of the solid-liquid ratio, most of the polysaccharide components in the Qishu medicinal material are dissolved in the extract, and the loss of polysaccharides will be reduced. When the solid-liquid ratio increases to a certain proportion, most of the polysaccharides have been dissolved, and the product extraction rate value fluctuates and decreases. Therefore, it is concluded that a solid-liquid ratio of about 1:30 is appropriate when setting the Qimen Atractylodes polysaccharide extraction scheme.

[0051] like Figure 1As shown in Figure B, as the extraction time gradually increases, the corresponding polysaccharide extraction results also change accordingly. The longer the reflux time, the higher the extraction rate, and the peak value appears when the extraction time is 2.5h, and then the extraction rate decreases as time increases. This result is mainly because it takes a certain amount of time for polysaccharides to separate from the medicinal materials and then dissolve in the water extract. When the reaction time is too short, some polysaccharides have not yet separated from the medicinal materials and entered the liquid. Therefore, as time goes by, the polysaccharides are more fully dissolved and the yield increases accordingly; when the peak value is reached, the polysaccharides will be decomposed as time goes by. Based on this, if the experimental efficiency is considered, the extraction time is preferably set to 2h, but if the final yield of the experiment is the object of investigation, it is best to set it to 2.5h.

[0052] like Figure 1 As shown in Figure C, as the temperature setting gradually increases, the polysaccharide yield also increases, and the extraction effect is optimal when the extraction temperature is 85°C. Different temperatures will not only cause changes in the solubility of polysaccharides, but also affect the structure of polysaccharides. When the temperature is too low, the solubility of polysaccharides will also decrease accordingly, and the polysaccharide extraction effect will deteriorate. When the extraction temperature is set higher, such as 95°C, although more polysaccharides are dissolved, some polysaccharides will decompose due to the high temperature, and the extraction rate will be affected to a certain extent. Therefore, it is concluded that when performing QAMP extraction operations, the temperature setting should be moderate, so the best temperature setting is 85°C.

[0053] like Figure 1 As shown in D, the increase in the number of extractions will increase the extraction rate accordingly, but after two extractions, the change in the results becomes smaller, which means that when the number of extractions increases to a certain number, the degree to which the polysaccharide extraction rate is affected by it will also decrease accordingly. Considering multiple factors such as efficiency loss, the optimal number of extractions in the experiment is 2 times.

[0054] 3. Orthogonal experiment to optimize the preparation process of Qimen Atractylodes macrocephala polysaccharide

[0055] According to the orthogonal table L9(34), the polysaccharide extraction rates under each group of conditions in the single factor investigation were compared, and three better design conditions among the four groups of factors, namely, solid-liquid ratio, extraction temperature, extraction time and extraction times, were selected as horizontal conditions. A four-factor three-level orthogonal experiment was carried out on the extraction process of Qimen Atractylodes polysaccharide water extraction and alcohol precipitation as shown in Tables 1 and 2 to finally obtain the optimal process design conditions.

[0056] Table 1 Orthogonal factor level table

[0057]

[0058] Table 2 Orthogonal test scheme and results

[0059]

[0060]

[0061] The experimental results show that the optimal experimental conditions should be set as: A2B1C2D3, that is, the solid-liquid ratio is 1:25, extraction at 85℃ for 2.5h, and repeated extraction for 3 times. Combined with the orthogonal test data results, the above experimental conditions were used for verification experiments to obtain a polysaccharide extraction rate of 27.37%, which is basically in line with the prediction.

[0062] Example 3 Structural Identification of Qimen Atractylodes Polysaccharide

[0063] 1. UV full wavelength scanning

[0064] The results of UV scanning of Qimen Atractylodes macrocephala polysaccharide are as follows Figure 2 As shown in the figure, it can be seen that Qimen Atractylodes macrocephala polysaccharide does not show obvious absorption peaks at 280nm and 260nm, indicating that Qimen Atractylodes macrocephala polysaccharide contains fewer impurities and basically does not contain protein and other components.

[0065] 2. Molecular weight determination

[0066] The logarithmic value of the relative molecular mass was used as the ordinate and the retention time (T) of the chromatographic peak was used as the abscissa to perform linear regression to obtain the calibration curves of Log Mp-T (peak molecular weight), Log Mw-T (weight average molecular weight), and LogMn-T (number average molecular weight), as shown below: Log Mp-T calibration curve equation: Log Mp-T = -0.1688T + 10.6871, R 2 =0.9926; Log Mw-T calibration curve equation: Log Mw-T = -0.1772T + 11.0909, R 2 =0.9936; Log Mn-T calibration curve equation: LogMn = -0.1685T + 10.5937, R 2 =0.9945.

[0067] The molecular weight distribution of Qimen Atractylodes macrocephala polysaccharide is shown in Figure 3 As shown in Table 3, the retention time of Qimen Atractylodes macrocephala polysaccharide is 42.758min. The molecular weight of Qimen Atractylodes macrocephala polysaccharide can be calculated by substituting it into the calibration equation, and ɑ=1.334 is calculated, which is close to 1, indicating that the molecular weight distribution of Qimen Atractylodes macrocephala polysaccharide is uniform. The peak near 47.9min is the mobile phase salt peak, and the peak after the mobile phase salt peak may contain small molecular components such as oligosaccharides.

[0068] Table 3 Molecular weight of Qimen Atractylodes macrocephala polysaccharide

[0069]

[0070] 3. Monosaccharide component analysis

[0071] The polysaccharide was decomposed into monosaccharides by acid hydrolysis, and the monosaccharide composition was qualitatively and quantitatively analyzed by ion chromatography. The mixed monosaccharide standard and Qimen Atractylodes macrocephala polysaccharide sample were tested to obtain the sequence of each monosaccharide standard (Table 4) and the sequence of Qimen Atractylodes macrocephala polysaccharide sample (Table 5), respectively. The ion chromatogram of the monosaccharide standard is shown in Figure 4 As shown in A, the ion chromatogram of Qimen Atractylodes macrocephala polysaccharide is as follows Figure 4 As shown in B, by comparison, it can be seen that Qimen Atractylodes macrocephala polysaccharide is mainly composed of fructose and glucose, with a molar ratio of 13:1.

[0072] Table 4 Monosaccharide standard sequence list

[0073]

[0074]

[0075] Table 5 Qimen Atractylodes macrocephala polysaccharide sample sequence list

[0076]

[0077] 4. Infrared spectrum detection

[0078] Infrared spectrum Figure 5 As shown in Figure 2, Qimen Atractylodes macrocephala polysaccharide is at 3394 cm -1 There is a broad and strong peak at 2930cm, which is the stretching vibration absorption peak of hydroxyl OH. -1 There is a weak absorption peak at 1200cm, which is caused by the symmetric stretching vibration of methylene CH. -1 ~1000cm -1 The stronger peak at 1640cm is the stretching vibration absorption peak of COH or COC and pyran ring. -1 It is the absorption peak related to water. 1410cm -1 The results showed that the polysaccharide of Qimen Atractylodes macrocephala contained a general polysaccharide structure.

[0079] 5. Methylation analysis

[0080] The results of methylation analysis of Qimen Atractylodes macrocephala polysaccharide are shown in Table 6. The monosaccharide residues and connection patterns of Qimen Atractylodes macrocephala polysaccharide are mainly: glucose residue connected at position 1 Glcp-(1→; fructose residue connected at position 1→1)-Fruf-(2→.

[0081] Table 6 Analysis results of sugar residue data of Qimen Atractylodes macrocephala polysaccharide

[0082]

[0083] 6. Nuclear Magnetic Resonance Analysis

[0084] In order to obtain the structural information of polysaccharide samples, one-dimensional NMR was performed 1 H-NMR, 13 C-NMR and two-dimensional nuclear magnetic COSY, HSQC, HMBC, and NOESY measurements were used to obtain all H and C chemical shift information of each major sugar residue and infer the connection sequence between each sugar residue.

[0085] One-dimensional H NMR spectroscopy ( 1 H-NMR) was used to further identify the glycosidic bond configuration of the polysaccharide sample. Most of the hydrogen spectrum signals of the polysaccharide were in the range of δ3.0 to 5.5 ppm, and usually δ4.5 to 5.5 ppm was the resonance region of the anomeric proton (H-1). 1 H-NMR spectrum ( Figure 6 ) can be seen from the anomeric region of δ4.5-5.5ppm, there is only one anomeric proton coupling signal, and there are three anomeric carbon signals between δ90.0 and 110.0ppm in the carbon spectrum. Combined with the HSQC spectrum, the sample spectrum is consistent with the spectral characteristics of fructan, which is consistent with the results of the methylation experiment.

[0086] Table 7. Sugar residues in QAMP 1 H and 13 Chemical shift assignment of C

[0087]

[0088] By NMR 13 C NMR spectrum ( Figure 7 ) and HSQC spectra ( Figure 8 ) showed that it may contain three kinds of sugar residues, and their anomeric carbon signals were δ103.58ppm, δ103.20ppm, and δ92.49ppm, respectively. Combined with the results of methylation analysis, the polysaccharide residues were classified as β-D-Fruf-(2→, →1)-β-D-Fruf-(2→, α-D-Glcp-(1→, respectively named F t 、F 2,1 , G t The results of monosaccharide composition analysis, methylation analysis and literature data show that the chemical shifts of the anomeric proton and anomeric carbon indicate that F t and F 2,1 The residue is in the β configuration, G t After the anomeric signal is determined, 1 H. 13 C. HSQC spectrum, combined with methylation results, compared with the chemical shift data of similar sugar substitutions in related literature, the main types of sugar residues in the polysaccharide sample were 1 H and 13The C chemical shift signals were assigned and the results are shown in Table 7.

[0089] By HMBC( Fig. 9 The coupling signals of the anomeric hydrogen and the carbon on each sugar residue, or the coupling signals of the anomeric carbon and the hydrogen on each sugar residue in the long-range correlation spectrum can further infer the interconnection order between each sugar residue. Fig. 9 As shown in the figure, the following coupling signals can be found: residue F 2,1 C-2 (δ103.20 ppm) and residue F 2,1 The H-1 (δ3.80ppm) has a coupling signal (F 2,1 C-2 / F 2,1 H-1), indicating the existence of a →1)-β-D-Fruf-(2→1)-β-D-Fruf-(2→ connecting fragment in the structure.

[0090] Linear fructans are generally based on 1-kestose as the basic unit, which is formed by connecting one or more furanose through β (2→1) bonds. Based on the monosaccharide composition, methylation results, and one-dimensional and two-dimensional NMR information analysis of the polysaccharide samples, the structure of the polysaccharide samples is more consistent with the structural characteristics of linear fructans. Its possible structural model is as follows Fig.10 As shown, the structural formula is β-D-Fruf-[(2→1)-β-D-Fruf] n -(2→1)-α-D-Glcp.

[0091] Example 4 Study on the therapeutic effect of Qimen Atractylodes macrocephala polysaccharide on DSS-induced ulcerative colitis model mice

[0092] 1. Establishment of ulcerative colitis mouse model

[0093] 90 mice were adaptively fed for 7 days, 10 mice were randomly selected as the blank group, and 80 mice were randomly selected as the model group. The mouse ulcerative colitis model was established using 3% DSS free drinking water for 7 days. The model group mice were divided into 8 groups: 1. UC model group (10 mice); 2. Qimen Atractylodes macrocephala polysaccharide low-dose group (QAMPL) (100 mg / kg); 3. Qimen Atractylodes macrocephala polysaccharide medium-dose group (QAMPM) (200 mg / kg); 4. Qimen Atractylodes macrocephala polysaccharide high-dose group (QAMPH) (400 mg / kg); 5. Bozhou Atractylodes macrocephala polysaccharide (with Haozhou Atractylodes macrocephala as raw material, the preparation method is the same as Example 1) low-dose group (BAMPL) (100 mg / kg); 6. Bozhou Atractylodes macrocephala polysaccharide medium-dose group (BAMPM) (200 mg / kg); 7. Bozhou Atractylodes macrocephala polysaccharide high-dose group (BAMPH) (400 mg / kg), 8. Positive drug group (mesalazine). Except for the positive drug group, the other drug groups were gavaged three days before modeling for 10 consecutive days; the positive drug group was administrated while modeling. After modeling, blood was collected from the eye canthus of the mice, and the mice were killed by cervical dislocation and colon tissue was obtained by dissection.

[0094] 2. Test items

[0095] Including: 1) Disease activity index (DAI) detection; 2) Histological examination (HE staining); 3) Immunohistochemistry detection of related protein expression in colon tissue; 4) Western blot detection of related protein expression in colon tissue; 5) Determination of serum IL-6, TL-1β and TNF-α levels; 6) CD68 in colon + Fluorescence detection of immune cells; 7) Changes in the content of short-chain fatty acids.

[0096] 3. Research Results

[0097] (1) Qimen Atractylodes macrocephala polysaccharide alleviates symptoms in UC mice

[0098] During the modeling period, the body weight and blood in stool of each group of mice were recorded and comprehensively scored according to the disease activity index (DAI), DAI = (body weight index + stool shape + bleeding) / 3. The DAI scoring table is shown in Table 8 below.

[0099] Table 8 DAI score table

[0100]

[0101] After the administration of Qimen Atractylodes macrocephala polysaccharide and Bozhou Atractylodes macrocephala polysaccharide, the two polysaccharides were able to significantly alleviate the symptoms of UC mice. Analysis of the weight changes and DAI score results of each group of mice (Tables 9-10) showed that the two polysaccharides were able to alleviate the weight loss of DSS-induced ulcerative colitis mice, and the DAI scores of the mice in the two polysaccharide administration groups were lower than those in the model group. Moreover, with the increase in the dosage of polysaccharides, the effect of alleviating the symptoms of UC mice became more obvious. Further observations through HE staining results showed that the two polysaccharides were able to alleviate the destruction of the colon mucosal structure and the loss of crypts in mice induced by DSS. And the therapeutic effect is positively correlated with the dosage of polysaccharides. The colon tissue pathology results of each group of mice are shown as follows Fig.11 These results indicate that Qimen Atractylodes macrocephala polysaccharides and Bozhou Atractylodes macrocephala polysaccharides can alleviate the weight loss, bloody stools, and colonic mucosal damage in DSS-induced ulcerative colitis mice.

[0102] Table 9 Body weight changes and DAI scores of mice in each group

[0103]

[0104] Table 10 Body weight changes and DAI scores of mice in each group

[0105]

[0106]

[0107] (2) Qimen Atractylodes macrocephala polysaccharides and Haozhou Atractylodes macrocephala polysaccharides can alleviate the inflammatory response of UC mice

[0108] ELISA results Fig.12 As shown in the figure: After 7 days of DSS induction in each group of mice, the expression levels of inflammatory factors IL-1β, IL-6 and TNF-α in the serum of the model group mice were significantly higher than those in the control group ( ## p<0.01). After the treatment with Qimen Atractylodes macrocephala polysaccharide and Bozhou Atractylodes macrocephala polysaccharide, the expression levels of inflammatory factors IL-1β, IL-6 and TNF-α in the serum of mice in the polysaccharide administration group were lower than those in the model group. Among them, the expression levels of inflammatory factors in the serum of mice in the high-dose Qimen Atractylodes macrocephala polysaccharide group and the high-dose Bozhou Atractylodes macrocephala polysaccharide group decreased most significantly (**p<0.05).

[0109] The results of immunofluorescence in the colon are as follows Fig.13 Shown: Inflammatory cells CD68 in the colon of model group mice 7 days after DSS induction + The number of inflammatory cells CD68 +The number of cells decreased, and the therapeutic effect became more obvious with the increase of the dosage. From these results, we can know that Qimen Atractylodes macrocephala polysaccharide and Bozhou Atractylodes macrocephala polysaccharide can alleviate the inflammatory response of DSS-induced UC mice.

[0110] (3) Qimen Atractylodes macrocephala polysaccharides and Bozhou Atractylodes macrocephala polysaccharides can restore the colon barrier function damage in UC mice

[0111] like Fig.14 As shown in the results, the expression of tight junction proteins in the colon of the UC model group mice was significantly reduced compared with the blank control group, while after administration of Qimen Atractylodes macrocephala polysaccharide and Bozhou Atractylodes macrocephala polysaccharide, the expression of tight junction proteins increased, and the effect became more significant with the increase in the dosage. It can be concluded that Qimen Atractylodes macrocephala polysaccharide and Bozhou Atractylodes macrocephala polysaccharide can restore the damage of colon barrier function caused by ulcerative colitis.

[0112] (4) Qimen Atractylodes macrocephala polysaccharides and Bozhou Atractylodes macrocephala polysaccharides down-regulate the expression of HDAC2 and up-regulate the expression of MCT-1 protein in the colon of UC mice

[0113] like Fig.15 As shown in the figure, the expression of MCT-1 in the colon of the UC model group mice was significantly reduced compared with the blank control group, indicating that the expression of MCT-1 protein in the colon of mice was inhibited under UC. After the intervention of Qimen Atractylodes macrocephala polysaccharide and Bozhou Atractylodes macrocephala polysaccharide, the expression of MCT-1 protein increased, and the effect became more significant with the increase of the dosage. It can be concluded that Qimen Atractylodes macrocephala polysaccharide and Bozhou Atractylodes macrocephala polysaccharide can upregulate the expression level of MCT-1 protein in the colon of ulcerative colitis.

[0114] According to the immunohistochemistry results obtained above, we further detected the expression changes of MCT-1 protein and HDAC2 protein in the colon of UC mice under the intervention of Qimen Atractylodes polysaccharide and Bozhou Atractylodes polysaccharide by Western Blot technology. Compared with the control group, the expression level of MCT-1 protein in the UC model group decreased, and the expression level of HDAC2 protein increased. This shows that the expression of MCT-1 protein in the colon of mice under UC is inhibited, while the expression level of HDAC2 protein is increased (p < 0.01). After the intervention of Qimen Atractylodes polysaccharide and Bozhou Atractylodes polysaccharide, the expression level of MCT-1 protein in the colon of mice increased, and the increasing trend became more obvious with the increase of dose. After the intervention of Qimen Atractylodes polysaccharide and Bozhou Atractylodes polysaccharide, the expression level of HDAC2 was inhibited, and the inhibition trend became more obvious with the increase of dose ( Fig.16Based on the above results, we can speculate that Qimen Atractylodes macrocephala polysaccharide and Bozhou Atractylodes macrocephala polysaccharide can inhibit the expression level of HDAC2 protein in UC mice and increase the protein expression level of MCT-1, thereby regulating the homeostasis of the colon immune system, achieving anti-inflammatory effects and improving ulcerative colitis.

[0115] (5) Qimen Atractylodes macrocephala polysaccharide and Bozhou Atractylodes macrocephala polysaccharide in the treatment of UC mice may be related to the influence on the content of short-chain fatty acids in the colon

[0116] like Fig.17 As shown in the figure, compared with the control group, the contents of acetic acid, propionic acid, n-butyric acid, isobutyric acid, n-valeric acid and isovaleric acid in the model group were significantly reduced (p<0.01), indicating that the content of SCFAs in the colon content decreased under UC. After the intervention of Qimen Atractylodes macrocephala polysaccharide and Bozhou Atractylodes macrocephala polysaccharide, the contents of acetic acid, propionic acid, n-butyric acid, isobutyric acid, n-valeric acid and isovaleric acid in the drug administration group were increased to varying degrees compared with the model group. With the increase of the dosage, the growth effect of various SCFAs was more obvious, and the difference between the high-dose polysaccharide administration group and the model group was the most obvious (p<0.05). Interestingly, after the administration of the positive drug (MSLQ), the contents of acetic acid, propionic acid, n-valeric acid and isovaleric acid in the colon content increased compared with the model group (p<0.05), but it had little effect on the changes in the contents of n-butyric acid and isobutyric acid. The high-dose polysaccharide group had similar effects on increasing the contents of acetic acid, propionic acid, valeric acid, and isovaleric acid in the colonic contents as the positive group, but the effects on increasing the contents of butyric acid and isobutyric acid were significantly higher than those in the positive drug group. In summary, we can infer that the Qimen Atractylodes macrocephala polysaccharide and the Bozhou Atractylodes macrocephala polysaccharide have different mechanisms of action from mesalazine in the treatment of UC. The two polysaccharides can significantly increase the content of butyrate in the colonic contents and play a role in the treatment of UC.

[0117] The preferred embodiments of the present invention are described in detail above. However, the present invention is not limited to the specific details in the above embodiments. Within the technical concept of the present invention, a variety of simple modifications can be made to the technical solution of the present invention, and these simple modifications all belong to the protection scope of the present invention.

Claims

1. A Qimen Atractylodes macrocephala polysaccharide, characterized in that: The weight average molecular weight of the Qimen Atractylodes macrocephala polysaccharide is 3000-4000 Da, and the structural formula is: β-D-Fruf-[(2→1)-β-D-Fruf] n -(2→1)-α-D-Glcp, in terms of molar ratio, Glcp:Fruf = 1:10-20; Among them, Fruf represents a fructose residue, Glcp represents a glucose residue, and 2→1 represents a glycosidic bond.

2. The Qimen Atractylodes macrocephala polysaccharide according to claim 1, characterized in that The weight average molecular weight of the Qimen Atractylodes macrocephala polysaccharide is 3267 Da.

3. The Qimen Atractylodes macrocephala polysaccharide according to claim 1, characterized in that In terms of molar ratio, Glcp:Fruf=1:

13.

4. Use of the Qimen Atractylodes macrocephala polysaccharide according to any one of claims 1 to 3 in the preparation of a medicament for treating ulcerative colitis.

5. The use according to claim 4, characterized in that: The drug is any one of the following 1) to 3): 1) Drugs that increase the content of short-chain fatty acids in the colon; 2) Drugs that inhibit histone deacetylase 2 activity; 3) Drugs that increase the content of monocarboxylate transporters.

6. A method for preparing Qimen Atractylodes macrocephala polysaccharide according to any one of claims 1 to 3, characterized in that: The preparation method comprises: The Qimen Atractylodes is dried and crushed, and then a lipophilic solvent is added to perform a first extraction, and the extracted product is filtered to obtain a precipitate, and after drying, a defatted Qimen Atractylodes is obtained; Water was added to the defatted Atractylodes macrocephala for a second extraction, the extract was concentrated and then precipitated with alcohol, and the precipitate was collected by centrifugation to obtain a crude Atractylodes macrocephala polysaccharide.

7. The preparation method according to claim 6, characterized in that: The lipophilic solvent is ethanol with a concentration of 85-95% v / v. The first extraction conditions include: the extraction solid-liquid ratio is 20g:400-600mL, and the reflux extraction is 1-3h.

8. The preparation method according to claim 6, characterized in that: The conditions of the second extraction include: the extraction solid-liquid ratio is 1 g: 20-30 mL, the extraction temperature is 85-95° C., and the extraction time is 2-3 h.

9. The preparation method according to claim 8, characterized in that: The conditions of the second extraction include: the solid-liquid ratio of the extraction is 1 g:25 mL, the extraction temperature is 85° C., and the extraction time is 2.5 h.

10. The preparation method according to claim 6, characterized in that: The preparation method further comprises: destarch, deproteinize, decolorize and perform column chromatography separation on the crude Qimen Atractylodes macrocephala polysaccharide to obtain the pure Qimen Atractylodes macrocephala polysaccharide.